English

SANGUI BIOTECH INTERNATIONAL INC.

EDGAR

Quarterly report (10-Q) · filed 2023-05-12

110 filing records in this dataset, filed from 2000-05-12 to 2023-05-12. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

18.7 thousand USD

2023 Q3 · USD

Exact inputs and evidence

Revenue: 18697 USD Source

Operating margin

-122.28%

2023 Q3 · %

Exact inputs and evidence

Operating Income: -22863 USD Source
Revenue: 18697 USD Source

Operating cash flow

251 USD

2023 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -20538 USD Source
Operating Cash Flow: -20789 USD Source

Cash and cash equivalents: 9.32 thousand USD 2022-12-31 Source
Exact value

9315 USD
Long-term debt including current maturities: Not available
Shares outstanding: 210 million shares 2023-03-31 Source
Exact value

209901842 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

209901842 shares · 2022-03-31· Source
209901842 shares · 2023-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

80.9 thousand USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Revenue: 69190 USD · 2021-07-01 – 2022-06-30 Source
Revenue: 58686 USD · 2021-07-01 – 2022-03-31 Source
Revenue: 41029 USD · 2022-07-01 – 2022-09-30 Source
Revenue: 10627 USD · 2022-10-01 – 2022-12-31 Source
Revenue: 18697 USD · 2023-01-01 – 2023-03-31 Source

Net income

-125 thousand USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Net income: -59310 USD · 2021-07-01 – 2022-06-30 Source
Net income: -51856 USD · 2021-07-01 – 2022-03-31 Source
Net income: 23232 USD · 2022-07-01 – 2022-09-30 Source
Net income: -102289 USD · 2022-10-01 – 2022-12-31 Source
Net income: -38191 USD · 2023-01-01 – 2023-03-31 Source

Operating cash flow

-57.9 thousand USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Operating cash flow: -140456 USD · 2021-07-01 – 2022-06-30 Source
Operating cash flow: -103119 USD · 2021-07-01 – 2022-03-31 Source
Operating cash flow: -25689 USD · 2022-07-01 – 2022-09-30 Source
Operating cash flow: -20789 USD · 2022-07-01 – 2022-12-31 Source
Operating cash flow: -25689 USD · 2022-07-01 – 2022-09-30 Source
Operating cash flow: -20538 USD · 2022-07-01 – 2023-03-31 Source
Operating cash flow: -20789 USD · 2022-07-01 – 2022-12-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-05-12.

Financial data available through: 2022-06-30.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2022-06-30
Operating income: 8 of 11 periods available· newest 2022-06-30
Net income: 11 of 11 periods available· newest 2022-06-30
Operating cash flow: 11 of 11 periods available· newest 2022-06-30
Capital expenditure: 2 of 11 periods available· newest 2021-06-30
Total assets: 11 of 11 periods available· newest 2022-06-30
Total liabilities: 4 of 11 periods available· newest 2022-06-30
Current assets: 11 of 11 periods available· newest 2022-06-30
Current liabilities: 11 of 11 periods available· newest 2022-06-30
Cash and cash equivalents: 11 of 11 periods available· newest 2022-06-30
long term debt: No compatible figures in this window
Shares outstanding: 7 of 11 periods available· newest 2022-06-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+5.5%

Prior period

USD 65,585

2020-07-01 – 2021-06-30
Current period

USD 69,190

2021-07-01 – 2022-06-30

Exact inputs and evidence

69190 − 65585 = 3605 USD

65585 USD · 2020-07-01 – 2021-06-30
Inspect prior input Prior source
69190 USD · 2021-07-01 – 2022-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · SANGUI BIOTECH INTERNATIONAL INC. · 2022-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Year-over-year change in Revenue: 3605 USD Concept: fundies:Revenue Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 69190 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000109690622002384/sgbi-20220630.htm#398001 Filing: 000109690622002384 Input fundies:Revenue: 65585 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000109690622002384/sgbi-20220630.htm#398526 Filing: 000109690622002384
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 139,580

Prior period

−USD 198,890

2020-07-01 – 2021-06-30
Current period

−USD 59,310

2021-07-01 – 2022-06-30

Exact inputs and evidence

-59310 − -198890 = 139580 USD

-198890 USD · 2020-07-01 – 2021-06-30
Inspect prior input Prior source
-59310 USD · 2021-07-01 – 2022-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · SANGUI BIOTECH INTERNATIONAL INC. · 2022-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Year-over-year change in Net income: 139580 USD Concept: fundies:NetIncome Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -59310 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000109690622002384/sgbi-20220630.htm#655388 Filing: 000109690622002384 Input fundies:NetIncome: -198890 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000109690622002384/sgbi-20220630.htm#427754 Filing: 000109690622002384
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 5,391

Prior period

−USD 145,847

2020-07-01 – 2021-06-30
Current period

−USD 140,456

2021-07-01 – 2022-06-30

Exact inputs and evidence

-140456 − -145847 = 5391 USD

-145847 USD · 2020-07-01 – 2021-06-30
Inspect prior input Prior source
-140456 USD · 2021-07-01 – 2022-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SANGUI BIOTECH INTERNATIONAL INC. · 2022-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Year-over-year change in Operating cash flow: 5391 USD Concept: fundies:OperatingCashFlow Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -140456 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000109690622002384/sgbi-20220630.htm#655602 Filing: 000109690622002384 Input fundies:OperatingCashFlow: -145847 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000109690622002384/sgbi-20220630.htm#613610 Filing: 000109690622002384
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2021-07-01 – 2022-06-30

Revenue USD 69,190 100% of revenue
Cost of revenue USD 0 0% of revenue
Operating expenses USD 208,636 302% of revenue
Operating income −USD 139,446 −202% of revenue
Tax, interest and other Derived −USD 80,136 −116% of revenue
Net income −USD 59,310 −86% of revenue

Cash

Operating cash flow −USD 140,456 −203% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2013 Not shown: operating income or net income is not reported.
2014 Not shown: operating income or net income is not reported.
2015 Not shown: operating income or net income is not reported.
2016 Operating loss: operating costs were 852% of revenue.
2017 Operating loss: operating costs were 568% of revenue.
2018 Operating loss: operating costs were 370% of revenue.
2019 Operating loss: operating costs were 484% of revenue.
2020 Operating loss: operating costs were 727% of revenue.
2021 Operating loss: operating costs were 330% of revenue.
2022 Operating loss: operating costs were 302% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2013 2012-07-01 – 2013-06-30	105487	Unavailable	Unavailable	Unavailable	-2263685	Unavailable	Source 2012-07-01 – 2013-06-30: 105487 USD Inspect Revenue Open source 2012-07-01 – 2013-06-30: -2263685 USD Inspect Net Income Open source 2012-07-01 – 2013-06-30: -841606 USD Inspect Operating Cash Flow Open source
2014 2013-07-01 – 2014-06-30	133470	Unavailable	Unavailable	Unavailable	-1571710	Unavailable	Source 2013-07-01 – 2014-06-30: 133470 USD Inspect Revenue Open source 2013-07-01 – 2014-06-30: -1571710 USD Inspect Net Income Open source 2013-07-01 – 2014-06-30: -760234 USD Inspect Operating Cash Flow Open source
2015 2014-07-01 – 2015-06-30	127469	Unavailable	Unavailable	Unavailable	-758408	Unavailable	Source 2014-07-01 – 2015-06-30: 127469 USD Inspect Revenue Open source 2014-07-01 – 2015-06-30: -758408 USD Inspect Net Income Open source 2014-07-01 – 2015-06-30: -602291 USD Inspect Operating Cash Flow Open source
2016 2015-07-01 – 2016-06-30	48009	408913 Derived	-360904	85456 Derived	-446360	Unavailable	Source 2015-07-01 – 2016-06-30: 48009 USD Inspect Revenue Open source 2015-07-01 – 2016-06-30: -360904 USD Inspect Operating Income Open source 2015-07-01 – 2016-06-30: -446360 USD Inspect Net Income Open source 2015-07-01 – 2016-06-30: -394757 USD Inspect Operating Cash Flow Open source
2017 2016-07-01 – 2017-06-30	67653	384452 Derived	-316799	13369 Derived	-330168	Unavailable	Source 2016-07-01 – 2017-06-30: 67653 USD Inspect Revenue Open source 2016-07-01 – 2017-06-30: -316799 USD Inspect Operating Income Open source 2016-07-01 – 2017-06-30: -330168 USD Inspect Net Income Open source 2016-07-01 – 2017-06-30: -323103 USD Inspect Operating Cash Flow Open source
2018 2017-07-01 – 2018-06-30	77152	285197 Derived	-208045	-6235 Derived	-201810	Unavailable	Source 2017-07-01 – 2018-06-30: 77152 USD Inspect Revenue Open source 2017-07-01 – 2018-06-30: -208045 USD Inspect Operating Income Open source 2017-07-01 – 2018-06-30: -201810 USD Inspect Net Income Open source 2017-07-01 – 2018-06-30: -253761 USD Inspect Operating Cash Flow Open source
2019 2018-07-01 – 2019-06-30	88001	425636 Derived	-337635	-14059 Derived	-323576	Unavailable	Source 2018-07-01 – 2019-06-30: 88001 USD Inspect Revenue Open source 2018-07-01 – 2019-06-30: -337635 USD Inspect Operating Income Open source 2018-07-01 – 2019-06-30: -323576 USD Inspect Net Income Open source 2018-07-01 – 2019-06-30: -316918 USD Inspect Operating Cash Flow Open source
2020 2019-07-01 – 2020-06-30	28915	210309 Derived	-181394	11347 Derived	-192741	-171484 Derived	Source 2019-07-01 – 2020-06-30: 28915 USD Inspect Revenue Open source 2019-07-01 – 2020-06-30: -181394 USD Inspect Operating Income Open source 2019-07-01 – 2020-06-30: -192741 USD Inspect Net Income Open source 2019-07-01 – 2020-06-30: -168386 USD Inspect Operating Cash Flow Open source 2019-07-01 – 2020-06-30: 3098 USD Inspect Capital Expenditure Open source
2021 2020-07-01 – 2021-06-30	65585	216723 Derived	-151138	47752 Derived	-198890	-145847 Derived	Source 2020-07-01 – 2021-06-30: 65585 USD Inspect Revenue Open source 2020-07-01 – 2021-06-30: -151138 USD Inspect Operating Income Open source 2020-07-01 – 2021-06-30: -198890 USD Inspect Net Income Open source 2020-07-01 – 2021-06-30: -145847 USD Inspect Operating Cash Flow Open source 2020-07-01 – 2021-06-30: 0 USD Inspect Capital Expenditure Open source
2022 2021-07-01 – 2022-06-30	69190	208636 Derived	-139446	-80136 Derived	-59310	Unavailable	Source 2021-07-01 – 2022-06-30: 69190 USD Inspect Revenue Open source 2021-07-01 – 2022-06-30: -139446 USD Inspect Operating Income Open source 2021-07-01 – 2022-06-30: -59310 USD Inspect Net Income Open source 2021-07-01 – 2022-06-30: -140456 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 69.2K 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-06-30	Revenue	105487	Revenue: 105487 Open source
20142014-06-30	Revenue	133470	Revenue: 133470 Open source
20152015-06-30	Revenue	127469	Revenue: 127469 Open source
20162016-06-30	Revenue	48009	Revenue: 48009 Open source
20172017-06-30	Revenue	67653	Revenue: 67653 Open source
20182018-06-30	Revenue	77152	Revenue: 77152 Open source
20192019-06-30	Revenue	88001	Revenue: 88001 Open source
20202020-06-30	Revenue	28915	Revenue: 28915 Open source
20212021-06-30	Revenue	65585	Revenue: 65585 Open source
20222022-06-30	Revenue	69190	Revenue: 69190 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

5.5% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20132013-06-30	Year over year	605.6%	Revenue: 105487 Open source Revenue: 14949 Open source
20142014-06-30	Year over year	26.5%	Revenue: 133470 Open source Revenue: 105487 Open source
20152015-06-30	Year over year	-4.5%	Revenue: 127469 Open source Revenue: 133470 Open source
20162016-06-30	Year over year	-62.3%	Revenue: 48009 Open source Revenue: 127469 Open source
20172017-06-30	Year over year	40.9%	Revenue: 67653 Open source Revenue: 48009 Open source
20182018-06-30	Year over year	14%	Revenue: 77152 Open source Revenue: 67653 Open source
20192019-06-30	Year over year	14.1%	Revenue: 88001 Open source Revenue: 77152 Open source
20202020-06-30	Year over year	-67.1%	Revenue: 28915 Open source Revenue: 88001 Open source
20212021-06-30	Year over year	126.8%	Revenue: 65585 Open source Revenue: 28915 Open source
20222022-06-30	Year over year	5.5%	Revenue: 69190 Open source Revenue: 65585 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -201.5% 2022

Net margin -85.7% 2022

Free cash flow margin -222.4% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2013-06-30	Operating margin	Not reported	Revenue: 105487 Open source
2014-06-30	Operating margin	Not reported	Revenue: 133470 Open source
2015-06-30	Operating margin	Not reported	Revenue: 127469 Open source
20162016-06-30	Operating margin	-751.7%	Operating Income: -360904 Open source Revenue: 48009 Open source
20172017-06-30	Operating margin	-468.3%	Operating Income: -316799 Open source Revenue: 67653 Open source
20182018-06-30	Operating margin	-269.7%	Operating Income: -208045 Open source Revenue: 77152 Open source
20192019-06-30	Operating margin	-383.7%	Operating Income: -337635 Open source Revenue: 88001 Open source
20202020-06-30	Operating margin	-627.3%	Operating Income: -181394 Open source Revenue: 28915 Open source
20212021-06-30	Operating margin	-230.4%	Operating Income: -151138 Open source Revenue: 65585 Open source
20222022-06-30	Operating margin	-201.5%	Operating Income: -139446 Open source Revenue: 69190 Open source
20132013-06-30	Net margin	-2,145.9%	Net Income: -2263685 Open source Revenue: 105487 Open source
20142014-06-30	Net margin	-1,177.6%	Net Income: -1571710 Open source Revenue: 133470 Open source
20152015-06-30	Net margin	-595%	Net Income: -758408 Open source Revenue: 127469 Open source
20162016-06-30	Net margin	-929.7%	Net Income: -446360 Open source Revenue: 48009 Open source
20172017-06-30	Net margin	-488%	Net Income: -330168 Open source Revenue: 67653 Open source
20182018-06-30	Net margin	-261.6%	Net Income: -201810 Open source Revenue: 77152 Open source
20192019-06-30	Net margin	-367.7%	Net Income: -323576 Open source Revenue: 88001 Open source
20202020-06-30	Net margin	-666.6%	Net Income: -192741 Open source Revenue: 28915 Open source
20212021-06-30	Net margin	-303.3%	Net Income: -198890 Open source Revenue: 65585 Open source
20222022-06-30	Net margin	-85.7%	Net Income: -59310 Open source Revenue: 69190 Open source
20132013-06-30	Free cash flow margin	Not reported	Revenue: 105487 Open source Operating Cash Flow: -841606 Open source
20142014-06-30	Free cash flow margin	Not reported	Revenue: 133470 Open source Operating Cash Flow: -760234 Open source
20152015-06-30	Free cash flow margin	Not reported	Revenue: 127469 Open source Operating Cash Flow: -602291 Open source
20162016-06-30	Free cash flow margin	Not reported	Revenue: 48009 Open source Operating Cash Flow: -394757 Open source
20172017-06-30	Free cash flow margin	Not reported	Revenue: 67653 Open source Operating Cash Flow: -323103 Open source
20182018-06-30	Free cash flow margin	Not reported	Revenue: 77152 Open source Operating Cash Flow: -253761 Open source
20192019-06-30	Free cash flow margin	Not reported	Revenue: 88001 Open source Operating Cash Flow: -316918 Open source
20202020-06-30	Free cash flow margin	-593.1%	Revenue: 28915 Open source Operating Cash Flow: -168386 Open source Capital Expenditure: 3098 Open source
20212021-06-30	Free cash flow margin	-222.4%	Revenue: 65585 Open source Operating Cash Flow: -145847 Open source Capital Expenditure: 0 Open source
20222022-06-30	Free cash flow margin	Not reported	Revenue: 69190 Open source Operating Cash Flow: -140456 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -140.5K 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-06-30	Operating cash flow	-841606	Operating Cash Flow: -841606 Open source
20142014-06-30	Operating cash flow	-760234	Operating Cash Flow: -760234 Open source
20152015-06-30	Operating cash flow	-602291	Operating Cash Flow: -602291 Open source
20162016-06-30	Operating cash flow	-394757	Operating Cash Flow: -394757 Open source
20172017-06-30	Operating cash flow	-323103	Operating Cash Flow: -323103 Open source
20182018-06-30	Operating cash flow	-253761	Operating Cash Flow: -253761 Open source
20192019-06-30	Operating cash flow	-316918	Operating Cash Flow: -316918 Open source
20202020-06-30	Operating cash flow	-168386	Operating Cash Flow: -168386 Open source
20212021-06-30	Operating cash flow	-145847	Operating Cash Flow: -145847 Open source
20222022-06-30	Operating cash flow	-140456	Operating Cash Flow: -140456 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -145.8K 2021

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-06-30	Free cash flow	Unavailable	Operating Cash Flow: -841606 Open source
20142014-06-30	Free cash flow	Unavailable	Operating Cash Flow: -760234 Open source
20152015-06-30	Free cash flow	Unavailable	Operating Cash Flow: -602291 Open source
20162016-06-30	Free cash flow	Unavailable	Operating Cash Flow: -394757 Open source
20172017-06-30	Free cash flow	Unavailable	Operating Cash Flow: -323103 Open source
20182018-06-30	Free cash flow	Unavailable	Operating Cash Flow: -253761 Open source
20192019-06-30	Free cash flow	Unavailable	Operating Cash Flow: -316918 Open source
20202020-06-30	Free cash flow	-171484	Operating Cash Flow: -168386 Open source Capital Expenditure: 3098 Open source
20212021-06-30	Free cash flow	-145847	Operating Cash Flow: -145847 Open source Capital Expenditure: 0 Open source
20222022-06-30	Free cash flow	Unavailable	Operating Cash Flow: -140456 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

784.3% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2013-06-30	Liabilities / assets	Not reported	Total Assets: 522978 Open source
2014-06-30	Liabilities / assets	Not reported	Total Assets: 260589 Open source
2015-06-30	Liabilities / assets	Not reported	Total Assets: 122099 Open source
2016-06-30	Liabilities / assets	Not reported	Total Assets: 110419 Open source
2017-06-30	Liabilities / assets	Not reported	Total Assets: 93773 Open source
2018-06-30	Liabilities / assets	Not reported	Total Assets: 102029 Open source
20192019-06-30	Liabilities / assets	849.6%	Total Liabilities: 670960 Open source Total Assets: 78971 Open source
20202020-06-30	Liabilities / assets	682.4%	Total Liabilities: 855206 Open source Total Assets: 125328 Open source
20212021-06-30	Liabilities / assets	752.6%	Total Liabilities: 1009447 Open source Total Assets: 134122 Open source
20222022-06-30	Liabilities / assets	784.3%	Total Liabilities: 1025745 Open source Total Assets: 130788 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.07× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20132013-06-30	Current assets / current liabilities	2.31×	Current Assets: 522529 Open source Current Liabilities: 226636 Open source
20142014-06-30	Current assets / current liabilities	1.03×	Current Assets: 260589 Open source Current Liabilities: 253313 Open source
20152015-06-30	Current assets / current liabilities	0.16×	Current Assets: 72099 Open source Current Liabilities: 461933 Open source
20162016-06-30	Current assets / current liabilities	0.31×	Current Assets: 110419 Open source Current Liabilities: 357985 Open source
20172017-06-30	Current assets / current liabilities	0.26×	Current Assets: 93773 Open source Current Liabilities: 354296 Open source
20182018-06-30	Current assets / current liabilities	0.23×	Current Assets: 102029 Open source Current Liabilities: 453173 Open source
20192019-06-30	Current assets / current liabilities	0.12×	Current Assets: 78971 Open source Current Liabilities: 670960 Open source
20202020-06-30	Current assets / current liabilities	0.06×	Current Assets: 48696 Open source Current Liabilities: 791485 Open source
20212021-06-30	Current assets / current liabilities	0.07×	Current Assets: 66666 Open source Current Liabilities: 954707 Open source
20222022-06-30	Current assets / current liabilities	0.07×	Current Assets: 67709 Open source Current Liabilities: 935619 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2013 2012-07-01 – 2013-06-30	−USD 2.26 million Exact value Exact value: -2263685 USD 2012-07-01 – 2013-06-30: -2263685 USD Inspect Net Income Open source Share or cite Citation for Net Income · SANGUI BIOTECH INTERNATIONAL INC. · 2013-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Net Income: -2263685 USD Concept: fundies:NetIncome Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3ANetIncome&period=2013-06-30&surface=latest&period_type=duration&start=2012-07-01&unit=USD&dimensions= Input fundies:NetIncome: -2263685 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000155116314000276/sgbi-20140630.xml#23506 Filing: 000155116314000276 The citation records this snapshot. The page link may show a newer release later.	−USD 841,606 Exact value Exact value: -841606 USD 2012-07-01 – 2013-06-30: -841606 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SANGUI BIOTECH INTERNATIONAL INC. · 2013-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Operating Cash Flow: -841606 USD Concept: fundies:OperatingCashFlow Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3AOperatingCashFlow&period=2013-06-30&surface=latest&period_type=duration&start=2012-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -841606 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000155116314000276/sgbi-20140630.xml#27244 Filing: 000155116314000276 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2013-07-01 – 2014-06-30	−USD 1.57 million Exact value Exact value: -1571710 USD 2013-07-01 – 2014-06-30: -1571710 USD Inspect Net Income Open source Share or cite Citation for Net Income · SANGUI BIOTECH INTERNATIONAL INC. · 2014-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Net Income: -1571710 USD Concept: fundies:NetIncome Period: 2013-07-01 to 2014-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3ANetIncome&period=2014-06-30&surface=latest&period_type=duration&start=2013-07-01&unit=USD&dimensions= Input fundies:NetIncome: -1571710 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000155116314000276/sgbi-20140630.xml#23392 Filing: 000155116314000276 The citation records this snapshot. The page link may show a newer release later.	−USD 760,234 Exact value Exact value: -760234 USD 2013-07-01 – 2014-06-30: -760234 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SANGUI BIOTECH INTERNATIONAL INC. · 2014-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Operating Cash Flow: -760234 USD Concept: fundies:OperatingCashFlow Period: 2013-07-01 to 2014-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3AOperatingCashFlow&period=2014-06-30&surface=latest&period_type=duration&start=2013-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -760234 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000155116315000227/sgbi-20150630.xml#142404 Filing: 000155116315000227 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2014-07-01 – 2015-06-30	−USD 758,408 Exact value Exact value: -758408 USD 2014-07-01 – 2015-06-30: -758408 USD Inspect Net Income Open source Share or cite Citation for Net Income · SANGUI BIOTECH INTERNATIONAL INC. · 2015-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Net Income: -758408 USD Concept: fundies:NetIncome Period: 2014-07-01 to 2015-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3ANetIncome&period=2015-06-30&surface=latest&period_type=duration&start=2014-07-01&unit=USD&dimensions= Input fundies:NetIncome: -758408 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000155116316000496/sgbi-20160630.xml#10376 Filing: 000155116316000496 The citation records this snapshot. The page link may show a newer release later.	−USD 602,291 Exact value Exact value: -602291 USD 2014-07-01 – 2015-06-30: -602291 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SANGUI BIOTECH INTERNATIONAL INC. · 2015-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Operating Cash Flow: -602291 USD Concept: fundies:OperatingCashFlow Period: 2014-07-01 to 2015-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3AOperatingCashFlow&period=2015-06-30&surface=latest&period_type=duration&start=2014-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -602291 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000155116316000496/sgbi-20160630.xml#16268 Filing: 000155116316000496 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2015-07-01 – 2016-06-30	−USD 446,360 Exact value Exact value: -446360 USD 2015-07-01 – 2016-06-30: -446360 USD Inspect Net Income Open source Share or cite Citation for Net Income · SANGUI BIOTECH INTERNATIONAL INC. · 2016-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Net Income: -446360 USD Concept: fundies:NetIncome Period: 2015-07-01 to 2016-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3ANetIncome&period=2016-06-30&surface=latest&period_type=duration&start=2015-07-01&unit=USD&dimensions= Input fundies:NetIncome: -446360 USD (2015-07-01 to 2016-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000155116317000171/sgbi-20170630.xml#16948 Filing: 000155116317000171 The citation records this snapshot. The page link may show a newer release later.	−USD 394,757 Exact value Exact value: -394757 USD 2015-07-01 – 2016-06-30: -394757 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SANGUI BIOTECH INTERNATIONAL INC. · 2016-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Operating Cash Flow: -394757 USD Concept: fundies:OperatingCashFlow Period: 2015-07-01 to 2016-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3AOperatingCashFlow&period=2016-06-30&surface=latest&period_type=duration&start=2015-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -394757 USD (2015-07-01 to 2016-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000155116317000171/sgbi-20170630.xml#8219 Filing: 000155116317000171 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2016-07-01 – 2017-06-30	−USD 330,168 Exact value Exact value: -330168 USD 2016-07-01 – 2017-06-30: -330168 USD Inspect Net Income Open source Share or cite Citation for Net Income · SANGUI BIOTECH INTERNATIONAL INC. · 2017-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Net Income: -330168 USD Concept: fundies:NetIncome Period: 2016-07-01 to 2017-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3ANetIncome&period=2017-06-30&surface=latest&period_type=duration&start=2016-07-01&unit=USD&dimensions= Input fundies:NetIncome: -330168 USD (2016-07-01 to 2017-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000155116318000148/sgbi-20180630.xml#10657 Filing: 000155116318000148 The citation records this snapshot. The page link may show a newer release later.	−USD 323,103 Exact value Exact value: -323103 USD 2016-07-01 – 2017-06-30: -323103 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SANGUI BIOTECH INTERNATIONAL INC. · 2017-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Operating Cash Flow: -323103 USD Concept: fundies:OperatingCashFlow Period: 2016-07-01 to 2017-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3AOperatingCashFlow&period=2017-06-30&surface=latest&period_type=duration&start=2016-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -323103 USD (2016-07-01 to 2017-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000155116318000148/sgbi-20180630.xml#14034 Filing: 000155116318000148 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2017-07-01 – 2018-06-30	−USD 201,810 Exact value Exact value: -201810 USD 2017-07-01 – 2018-06-30: -201810 USD Inspect Net Income Open source Share or cite Citation for Net Income · SANGUI BIOTECH INTERNATIONAL INC. · 2018-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Net Income: -201810 USD Concept: fundies:NetIncome Period: 2017-07-01 to 2018-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3ANetIncome&period=2018-06-30&surface=latest&period_type=duration&start=2017-07-01&unit=USD&dimensions= Input fundies:NetIncome: -201810 USD (2017-07-01 to 2018-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000144586619001219/sgbi-20190630.htm#363611 Filing: 000144586619001219 The citation records this snapshot. The page link may show a newer release later.	−USD 253,761 Exact value Exact value: -253761 USD 2017-07-01 – 2018-06-30: -253761 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SANGUI BIOTECH INTERNATIONAL INC. · 2018-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Operating Cash Flow: -253761 USD Concept: fundies:OperatingCashFlow Period: 2017-07-01 to 2018-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3AOperatingCashFlow&period=2018-06-30&surface=latest&period_type=duration&start=2017-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -253761 USD (2017-07-01 to 2018-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000144586619001219/sgbi-20190630.htm#534594 Filing: 000144586619001219 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2018-07-01 – 2019-06-30	−USD 323,576 Exact value Exact value: -323576 USD 2018-07-01 – 2019-06-30: -323576 USD Inspect Net Income Open source Share or cite Citation for Net Income · SANGUI BIOTECH INTERNATIONAL INC. · 2019-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Net Income: -323576 USD Concept: fundies:NetIncome Period: 2018-07-01 to 2019-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3ANetIncome&period=2019-06-30&surface=latest&period_type=duration&start=2018-07-01&unit=USD&dimensions= Input fundies:NetIncome: -323576 USD (2018-07-01 to 2019-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000155116321000017/sgbi-20200630.xml#13752 Filing: 000155116321000017 The citation records this snapshot. The page link may show a newer release later.	−USD 316,918 Exact value Exact value: -316918 USD 2018-07-01 – 2019-06-30: -316918 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SANGUI BIOTECH INTERNATIONAL INC. · 2019-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Operating Cash Flow: -316918 USD Concept: fundies:OperatingCashFlow Period: 2018-07-01 to 2019-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3AOperatingCashFlow&period=2019-06-30&surface=latest&period_type=duration&start=2018-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -316918 USD (2018-07-01 to 2019-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000155116321000017/sgbi-20200630.xml#35153 Filing: 000155116321000017 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2019-07-01 – 2020-06-30	−USD 192,741 Exact value Exact value: -192741 USD 2019-07-01 – 2020-06-30: -192741 USD Inspect Net Income Open source Share or cite Citation for Net Income · SANGUI BIOTECH INTERNATIONAL INC. · 2020-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Net Income: -192741 USD Concept: fundies:NetIncome Period: 2019-07-01 to 2020-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3ANetIncome&period=2020-06-30&surface=latest&period_type=duration&start=2019-07-01&unit=USD&dimensions= Input fundies:NetIncome: -192741 USD (2019-07-01 to 2020-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000109690621002362/sgbi-20210630.htm#408466 Filing: 000109690621002362 The citation records this snapshot. The page link may show a newer release later.	−USD 168,386 Exact value Exact value: -168386 USD 2019-07-01 – 2020-06-30: -168386 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SANGUI BIOTECH INTERNATIONAL INC. · 2020-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Operating Cash Flow: -168386 USD Concept: fundies:OperatingCashFlow Period: 2019-07-01 to 2020-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3AOperatingCashFlow&period=2020-06-30&surface=latest&period_type=duration&start=2019-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -168386 USD (2019-07-01 to 2020-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000109690621002362/sgbi-20210630.htm#593598 Filing: 000109690621002362 The citation records this snapshot. The page link may show a newer release later.	USD 3,098 Exact value Exact value: 3098 USD 2019-07-01 – 2020-06-30: 3098 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SANGUI BIOTECH INTERNATIONAL INC. · 2020-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Capital Expenditure: 3098 USD Concept: fundies:CapitalExpenditure Period: 2019-07-01 to 2020-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3ACapitalExpenditure&period=2020-06-30&surface=latest&period_type=duration&start=2019-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3098 USD (2019-07-01 to 2020-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000109690621002362/sgbi-20210630.htm#597132 Filing: 000109690621002362 The citation records this snapshot. The page link may show a newer release later.	−USD 171,484 Calculation and evidence -168386 − 3098 USD Exact free cash flow: -171484 USD 2019-07-01 – 2020-06-30: -168386 USD · Inspect Operating Cash Flow · Source 2019-07-01 – 2020-06-30: 3098 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SANGUI BIOTECH INTERNATIONAL INC. · 2020-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Free cash flow: -171484 USD Concept: free-cash-flow Period: 2019-07-01 to 2020-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -168386 USD (2019-07-01 to 2020-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000109690621002362/sgbi-20210630.htm#593598 Filing: 000109690621002362 Input fundies:CapitalExpenditure: 3098 USD (2019-07-01 to 2020-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000109690621002362/sgbi-20210630.htm#597132 Filing: 000109690621002362 The citation records this snapshot. The page link may show a newer release later.
2021 2020-07-01 – 2021-06-30	−USD 198,890 Exact value Exact value: -198890 USD 2020-07-01 – 2021-06-30: -198890 USD Inspect Net Income Open source Share or cite Citation for Net Income · SANGUI BIOTECH INTERNATIONAL INC. · 2021-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Net Income: -198890 USD Concept: fundies:NetIncome Period: 2020-07-01 to 2021-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3ANetIncome&period=2021-06-30&surface=latest&period_type=duration&start=2020-07-01&unit=USD&dimensions= Input fundies:NetIncome: -198890 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000109690622002384/sgbi-20220630.htm#427754 Filing: 000109690622002384 The citation records this snapshot. The page link may show a newer release later.	−USD 145,847 Exact value Exact value: -145847 USD 2020-07-01 – 2021-06-30: -145847 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SANGUI BIOTECH INTERNATIONAL INC. · 2021-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Operating Cash Flow: -145847 USD Concept: fundies:OperatingCashFlow Period: 2020-07-01 to 2021-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3AOperatingCashFlow&period=2021-06-30&surface=latest&period_type=duration&start=2020-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -145847 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000109690622002384/sgbi-20220630.htm#613610 Filing: 000109690622002384 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2020-07-01 – 2021-06-30: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SANGUI BIOTECH INTERNATIONAL INC. · 2021-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2020-07-01 to 2021-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3ACapitalExpenditure&period=2021-06-30&surface=latest&period_type=duration&start=2020-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000109690621002362/sgbi-20210630.htm#596519 Filing: 000109690621002362 The citation records this snapshot. The page link may show a newer release later.	−USD 145,847 Calculation and evidence -145847 − 0 USD Exact free cash flow: -145847 USD 2020-07-01 – 2021-06-30: -145847 USD · Inspect Operating Cash Flow · Source 2020-07-01 – 2021-06-30: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SANGUI BIOTECH INTERNATIONAL INC. · 2021-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Free cash flow: -145847 USD Concept: free-cash-flow Period: 2020-07-01 to 2021-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -145847 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000109690622002384/sgbi-20220630.htm#613610 Filing: 000109690622002384 Input fundies:CapitalExpenditure: 0 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000109690621002362/sgbi-20210630.htm#596519 Filing: 000109690621002362 The citation records this snapshot. The page link may show a newer release later.
2022 2021-07-01 – 2022-06-30	−USD 59,310 Exact value Exact value: -59310 USD 2021-07-01 – 2022-06-30: -59310 USD Inspect Net Income Open source Share or cite Citation for Net Income · SANGUI BIOTECH INTERNATIONAL INC. · 2022-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Net Income: -59310 USD Concept: fundies:NetIncome Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3ANetIncome&period=2022-06-30&surface=latest&period_type=duration&start=2021-07-01&unit=USD&dimensions= Input fundies:NetIncome: -59310 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000109690622002384/sgbi-20220630.htm#655388 Filing: 000109690622002384 The citation records this snapshot. The page link may show a newer release later.	−USD 140,456 Exact value Exact value: -140456 USD 2021-07-01 – 2022-06-30: -140456 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SANGUI BIOTECH INTERNATIONAL INC. · 2022-06-30 SANGUI BIOTECH INTERNATIONAL INC. (edgar:1104280) Operating Cash Flow: -140456 USD Concept: fundies:OperatingCashFlow Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-03T00:07:48Z Snapshot: b99465d6a1667dbffb43bfb25e4d0e3a7a6f99bd282a041b598f7394a234bca2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1104280/explain?concept=fundies%3AOperatingCashFlow&period=2022-06-30&surface=latest&period_type=duration&start=2021-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -140456 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1104280/000109690622002384/sgbi-20220630.htm#655602 Filing: 000109690622002384 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

110 filings · 2,702 latest values · 2,702 originally reported values

Dataset published 2026-11-03. Source filing dates and reporting periods are shown separately.

Identifiers: 0001104280, 1104280, edgar:1104280, sgbi

Also known as FELNAM INVESTMENTS INC, SANGUI BIOTECH INTERNATIONAL INC, SANGUI BIOTECH INTERNATIONAL INC.

SANGUI BIOTECH INTERNATIONAL INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2022 2021-07-01 – 2022-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation